Eikon Therapeutics, Inc. (EIKN)

NASDAQ:EIKN

US Market

EIKN

Eikon Therapeutics, Inc.

RESEARCH TOOLSreports

Eikon Therapeutics, Inc. (EIKN) Ownership - Who Owns Eikon Therapeutics, Inc.?

13 Followers

Eikon Therapeutics, Inc. (EIKN) Ownership Overview

22.32% Insiders

19.09% Other Institutional Investors

2.15% ETFs

56.44% Public Companies and

Individual Investors

The ownership structure of Eikon Therapeutics, Inc. (EIKN) stock is a mix of institutional, retail, and individual investors. , 22.32% is owned by Insiders, and 56.44% is owned by Public Companies and Individual Investors.

The ownership structure of Eikon Therapeutics, Inc. (EIKN) stock is a mix of institutional, retail, and individual investors. Approximately 21.24% of the company’s stock is owned by Institutional Investors, 22.32% is owned by Insiders, and 56.44% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Feb 09, 2026	Column Group Gp Iv Lp	xxxxxxxxxxxxx	$38119680
Feb 06, 2026	Lux Venture Partners V, Llc	xxxxxxxxxxxxx	$4999968
Feb 06, 2026	Foresite Capital Management Iv, Llc	xxxxxxxxxxxxx	$999990
Feb 06, 2026	Josh Wolfe	xxxxxxxxxxxxx	$4999968

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2026	Baker Bros Advisors Lp	xxxxxxxxxxxxx	$5877772
Mar 31, 2026	Blackstone Inc.	xxxxxxxxxxxxx	$1781016

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	5,780,143	Insider	10.68%	55,547,174
	2,294,653	Insider	4.24%	22,051,615
	2,294,653	Insider	4.24%	22,051,615
	1,318,983	Insider	2.44%	12,675,427
	960,704	Institution	1.77%	9,232,365
Felix Baker	555,555	Institution	1.03%	5,338,884
	284,857	Insider	0.53%	2,737,476
Stephen A. Schwarzman	168,338	Institution	0.31%	1,617,728
	115,322	Institution	0.21%	1,108,244
	111,111	Insider	0.21%	1,067,777

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	711,917	Institution	1.31%	7,717,180
Vanguard Extended Market ETF	235,174	Institution	0.43%	2,549,286
Schwab U.S. Small-Cap ETF	99,766	Institution	0.18%	970,723
ALPS Medical Breakthroughs ETF	54,020	Institution	0.10%	519,132
ProShares Nanotechnology ETF	25,156	Institution	0.05%	241,749
Schwab U.S. Broad Market ETF	15,556	Institution	0.03%	151,360
Vanguard Russell 2000 ETF	11,872	Institution	0.02%	128,692
T. Rowe Price Health Care ETF	7,419	Institution	0.01%	72,187
Future Health ETF	1,253	Institution	<0.01%	12,192
Vanguard Russell 2000 Growth ETF	1,156	Institution	<0.01%	12,531

FAQ

Who Owns Eikon Therapeutics, Inc. (EIKN)?

According to the latest TipRanks data, approximately 19.09% of the company's stock is held by institutional investors, 22.32% is held by insiders, and 56.44% is held by retail investors.

What percentage of Eikon Therapeutics, Inc. (EIKN) stock is held by institutional investors?

According to the latest TipRanks data, approximately 19.09% of Eikon Therapeutics, Inc. (EIKN) stock is held by institutional investors.

What percentage of Eikon Therapeutics, Inc. (EIKN) stock is held by retail investors?

According to the latest TipRanks data, approximately 56.44% of Eikon Therapeutics, Inc. (EIKN) stock is held by retail investors.

Who owns the most shares of Eikon Therapeutics, Inc. (EIKN)?

Column Group GP IV LP owns the most shares of Eikon Therapeutics, Inc. (EIKN).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.